Cargando…
Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer’s Disease
Alzheimer’s disease (AD) is an age-associated terminal neurodegenerative disease with no effective treatments. Dysfunction of innate immunity is implicated in the pathogenesis of AD, with genetic studies supporting a causative role in the disease. Microglia, the effector cells of innate immunity in...
Autores principales: | Fairley, Lauren H., Wong, Jia Hui, Barron, Anna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947196/ https://www.ncbi.nlm.nih.gov/pubmed/33717134 http://dx.doi.org/10.3389/fimmu.2021.624538 |
Ejemplares similares
-
Microglial Immunometabolism in Alzheimer’s Disease
por: Shippy, Daniel C., et al.
Publicado: (2020) -
Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer’s disease
por: Fairley, Lauren H., et al.
Publicado: (2023) -
Deficiency of the Circadian Clock Gene Bmal1 Reduces Microglial Immunometabolism
por: Wang, Xiao-Lan, et al.
Publicado: (2020) -
Research Progress on the Mechanism of Itaconate Regulating Macrophage Immunometabolism
por: Shi, Jia, et al.
Publicado: (2022) -
Immunometabolism in Tuberculosis
por: Shi, Lanbo, et al.
Publicado: (2016)